Fight Against Covid 19 (2025)

25/04/2020

Disposable face mask in stock !
we always update our products because of the demand of clients !
Visit and take your 50-100 stock for yourself and your familly :
https://fightagainstcovid19-93.webself.net/

25/04/2020

Stay healthy, Stay strong !

19/04/2020

Top teen infected Places in the US :
New York City
Confirmed :134,436
Recovered : 18,018
Dead : 10,022
Nassau County
30,013
1,271
1,281
Suffolk County
27,364
1,576
693
Westchester County
23,803
9,371
668
Rockland County
9,364
4,975
334
Orange County
6,514
0
211
Dutchess County
2,240
233
49

15/04/2020

Thank you from the bottom of our heart

14/04/2020

Q. What is physical distancing and why and how should I do it?

Physical distancing aims to reduce physical contact between potentially infected people and healthy people, or between population groups with high rates of transmission and others with low or no level of transmission. The objective of this is to decrease or interrupt the spread of COVID-19.

Note that the term ‘physical distancing’ means the same thing as the widely used term ‘social distancing’, but it more accurately describes what is intended, namely that people keep physically apart. Physical distancing measures might be implemented over an extended period and their success depends on ensuring that people maintain social contact – from a distance – with friends, family and colleagues. Internet-based communications and the phone are therefore key tools for ensuring a successful physical distancing strategy.

On a personal level, you can perform physical distancing measures by:

Voluntarily self-isolating if you know you have the virus that causes COVID-19, or if you have suggestive respiratory symptoms, or if you belong to a high-risk group (i.e. you are aged 70 years or more, or you have an underlying health condition).
Many countries in the EU/EEA and the UK have installed quarantine and social/physical distancing as measures to prevent the further spread of the virus.

These measures can include:

The full or partial closure of educational institutions and workplaces;
Limiting the number of visitors and limiting the contact between the residents of confined settings, such as long-term care facilities and prisons;
Cancellation, prohibition and restriction of mass gatherings and smaller meetings;

14/04/2020

Q. How can we differentiate between hay fever/pollen allergy related respiratory symptoms and COVID-19 infection?

A.Someone with COVID-19 usually has mild, flu-like symptoms (see above question 1), which are rather common and need to be distinguished from similar symptoms caused by common cold viruses and from allergic symptoms during springtime.

The following table presents a comparison of the most common symptoms of all three conditions according to their reported frequency.

It is good to bear in mind that the definitive diagnosis of COVID-19 is not clinical, but through laboratory testing of a sample from the nose or mouth.

14/04/2020

Q. Do persons suffering from pollen allergy or allergies in general have a higher risk to develop severe disease when having COVID-19?

A.A large proportion of the population (up to 15-20%) reports seasonal symptoms related to pollen, the most common of which include itchy eyes, nasal congestion, runny nose and sometimes wheezing and skin rash. All these symptoms are usually referred to as hay fever, pollen allergy or more appropriately allergic rhinitis. Allergic rhinitis is commonly associated with allergic asthma in children and adults.

Allergies, including mild allergic asthma, have not been identified as a major risk factor for SARS-CoV-2 infection or for a more unfavourable outcome in the studies available so far. Moderate to severe asthma on the other hand, where patients need treatment daily, is included in the chronic lung conditions that predispose to severe disease.

Children and adults on maintenance medication for allergies (e.g. leukotriene inhibitors, inhaled corticosteroids and/or bronchodilators) need to continue their treatment as prescribed by their doctor and should not discontinue their medication due to fears of COVID-19. If they develop symptoms compatible with COVID-19, they will need to self-isolate, inform their doctor and monitor their health as everyone else. If progressive difficulty breathing develops, they should seek prompt medical assistance.

14/04/2020

Q. Where can I get tested?

A.If you are feeling ill with COVID-19 symptoms (such as fever, cough, difficulty breathing, muscle pain or general weakness), it is recommended that you contact your local healthcare services online or by telephone. If your healthcare provider believes there is a need for a laboratory test for the virus that causes COVID-19, he/she will inform you of the procedure to follow and advise where and how the test can be performed.

14/04/2020

Q. When should I be tested for COVID-19?

A.Current advice for testing depends on the stage of the outbreak in the country or area where you live. Testing approaches will be adapted to the situation at national and local level. National authorities may decide to test only subgroups of suspected cases based on the national capacity to test, the availability of necessary equipment for testing, the level of community transmission of COVID-19, or other criteria.

As a resource conscious approach, ECDC has suggested that national authorities may consider prioritising testing in the following groups:

hospitalised patients with severe respiratory infections;
symptomatic healthcare staff including those with mild symptoms;
cases with acute respiratory infections in hospital or long-term care facilities;
patients with acute respiratory infections or influenza-like illness in certain outpatient clinics or hospitals;
elderly people with underlying chronic medical conditions such as lung disease, cancer, heart failure, cerebrovascular disease, renal disease, liver disease, diabetes, and immunocompromising conditions.

14/04/2020

Q. Is there a treatment for the COVID-19 disease?

A.There is no specific treatment or vaccine for this disease.

Healthcare providers are mostly using a symptomatic approach, meaning they treat the symptoms rather than target the virus, and provide supportive care (e.g. oxygen therapy, fluid management) for infected persons, which can be highly effective.

In severe and critically ill patients, a number of drugs are being tried to target the virus, but the use of these need to be more carefully assessed in randomised controlled trials. Several clinical trials are ongoing to assess their effectiveness but results are not yet available.

As this is a new virus, no vaccine is currently available. Although work on a vaccine has already started by several research groups and pharmaceutical companies worldwide, it may be months to more than a year before a vaccine has been tested and is ready for use in humans.

14/04/2020

Q. What is the risk of infection in pregnant women and neonates?

A.There is limited scientific evidence on the severity of illness in pregnant women after COVID-19 infection. It seems that pregnant women appear to experience similar clinical manifestations as non-pregnant women who have progressed to COVID-19 pneumonia and to date (as of 25 March), there have been no maternal deaths, no pregnancy losses and only one stillbirth reported. No current evidence suggests that infection with COVID-19 during pregnancy has a negative effect on the foetus. At present, there is no evidence of transmission of COVID-19 from mother to baby during pregnancy and only one confirmed COVID-19 neonatal case has been reported to date.

ECDC will continue to monitor the emerging scientific literature on this question, and suggests that all pregnant women follow the same general precautions for the prevention of COVID-19, including regular handwashing, avoiding individuals who are sick, and self-isolating in case of any symptoms, while consulting a healthcare provider by telephone for advice.

14/04/2020

Q. Are children also at risk of infection and what is their potential role in transmission?

A.Children make up a very small proportion of reported COVID-19 cases, with about 1% of all cases reported being under 10 years, and 4% aged 10-19 years. Children appear as likely to be infected as adults, but they have a much lower risk than adults of developing symptoms or severe disease. There is still some uncertainty about the extent to which asymptomatic or mildly symptomatic children transmit disease.

Fight Against Covid 19

25/04/2020

25/04/2020

19/04/2020

15/04/2020

14/04/2020

14/04/2020

14/04/2020

14/04/2020

14/04/2020

14/04/2020

14/04/2020

14/04/2020

Address

Website

Alerts

Shortcuts

Share